LDH-IN-3
LDH-IN-3 (E38) is a lactate dehydrogenase (LDH) inhibitor investigated for its neuroprotective potential in models of ischemic injury to the retina and brain. Its mechanism of action is associated with the activation of the HO-1/SIRT1 signaling pathway, as evidenced in preclinical studies.
Product Specifications
Field of Research
Metabolism Research
Molecular Formula
C32H27NO5
Molecular Weight
505.56
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
RPU50187-01 50 µg
OVA Conjugated Human Calcitonin Gene Related Peptide (CGRP)
Sign In for Pricing
View Details 
RPU50187-02 100 µg
OVA Conjugated Human Calcitonin Gene Related Peptide (CGRP)
Sign In for Pricing
View Details RPU50187-03 1 mg
OVA Conjugated Human Calcitonin Gene Related Peptide (CGRP)
Sign In for Pricing
View Details 